• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原的F2 kringle催化结构域连接子不覆盖纤维蛋白原识别外位点的晶体学证据。

Crystallographic evidence that the F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite.

作者信息

van de Locht A, Stubbs M T, Bauer M, Bode W

机构信息

Department of Structural Research, Max Planck Institute for Biochemistry, D-82152 Martinsried, Germany.

出版信息

J Biol Chem. 1996 Feb 16;271(7):3413-6. doi: 10.1074/jbc.271.7.3413.

DOI:10.1074/jbc.271.7.3413
PMID:8631941
Abstract

The 2.6-A x-ray crystal structure of bovine alpha-thrombin in complex with rhodniin, a protein inhibitor isolated from the bug Rhodnius prolixus, has been solved and refined. The structure has enabled us to trace the N-terminal part of the 49-residue A-chain of bovine alpha-thrombin for the first time, which is fixed in a U-shaped loop on the molecular surface opposite the active site canyon. Model building shows that the 25 amino acid residues that link the A-chain and F2 kringle cannot run through the fibrinogen recognition exosite. This demonstrates that this fibrinogen recognition exosite is available in prothrombin and meizothrombin.

摘要

已解析并优化了牛α-凝血酶与红猎蝽蛋白抑制剂罗德尼因(rhodniin)复合物的2.6埃X射线晶体结构,该抑制剂是从昆虫长红猎蝽(Rhodnius prolixus)中分离得到的。该结构首次使我们能够追踪牛α-凝血酶49个残基A链的N端部分,其固定在与活性位点峡谷相对的分子表面的一个U形环中。模型构建表明,连接A链和F2 kringle的25个氨基酸残基无法穿过纤维蛋白原识别外位点。这表明该纤维蛋白原识别外位点在凝血酶原和中凝血酶中是存在的。

相似文献

1
Crystallographic evidence that the F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite.凝血酶原的F2 kringle催化结构域连接子不覆盖纤维蛋白原识别外位点的晶体学证据。
J Biol Chem. 1996 Feb 16;271(7):3413-6. doi: 10.1074/jbc.271.7.3413.
2
New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.从牛中凝血酶原F1缺失体与PPACK复合物的X射线晶体结构中获得的关于血液凝固级联调节的新见解。
Structure. 1997 Dec 15;5(12):1681-93. doi: 10.1016/s0969-2126(97)00314-6.
3
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.三个臭皮匠,顶个诸葛亮:昆虫源双结构域Kazal抑制剂红猎蝽素与凝血酶复合物的晶体结构
EMBO J. 1995 Nov 1;14(21):5149-57. doi: 10.1002/j.1460-2075.1995.tb00199.x.
4
Localization of the thrombin-binding domain on prothrombin fragment 2.凝血酶原片段2上凝血酶结合结构域的定位
J Biol Chem. 1998 Apr 10;273(15):8932-9. doi: 10.1074/jbc.273.15.8932.
5
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.人及牛凝血酶原片段2与人类PPACK-凝血酶的非共价复合物结构
Biochemistry. 1993 May 11;32(18):4727-37. doi: 10.1021/bi00069a006.
6
Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin.凝血酶原kringle 2与PPACK-凝血酶的非共价复合物结构。
Chem Phys Lipids. 1994 Jan;67-68:59-66. doi: 10.1016/0009-3084(94)90124-4.
7
Homology modeling and molecular dynamics simulation of human prothrombin fragment 1.人凝血酶原片段1的同源建模与分子动力学模拟
Protein Sci. 1995 Nov;4(11):2341-8. doi: 10.1002/pro.5560041112.
8
Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin.血液凝固因子Xa与凝血酶原kringle 2结构域的线性序列相互作用。
J Biochem. 1994 Sep;116(3):589-97. doi: 10.1093/oxfordjournals.jbchem.a124565.
9
Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.葡萄球菌凝固酶对纤维蛋白原底物的识别。(原)凝血酶复合物。
J Biol Chem. 2006 Jan 13;281(2):1179-87. doi: 10.1074/jbc.M507956200. Epub 2005 Oct 17.
10
The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.D-苯丙氨酸-脯氨酸-精氨酸氯甲基酮抑制的人α-凝血酶的精制1.9埃X射线晶体结构:结构分析、整体结构、静电性质、详细的活性位点几何结构及结构-功能关系
Protein Sci. 1992 Apr;1(4):426-71. doi: 10.1002/pro.5560010402.

引用本文的文献

1
Proteases as therapeutics.蛋白酶作为治疗药物。
Biochem J. 2011 Apr 1;435(1):1-16. doi: 10.1042/BJ20100965.
2
Characterization of bothrojaracin interaction with human prothrombin.Bothrojaracin与人凝血酶原相互作用的表征。
Protein Sci. 2001 Sep;10(9):1897-904. doi: 10.1110/ps.09001.